Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2003-10-14
pubmed:abstractText
Botulinum toxin type A (BTXA) is used to treat neurologic disorders associated with increased muscle tone. Its use is often associated with pain relief.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1526-632X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
14
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
940-4
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:14557564-Adult, pubmed-meshheading:14557564-Analgesics, pubmed-meshheading:14557564-Botulinum Toxins, Type A, pubmed-meshheading:14557564-Capsaicin, pubmed-meshheading:14557564-Double-Blind Method, pubmed-meshheading:14557564-Electric Stimulation, pubmed-meshheading:14557564-Female, pubmed-meshheading:14557564-Forearm, pubmed-meshheading:14557564-Hot Temperature, pubmed-meshheading:14557564-Humans, pubmed-meshheading:14557564-Hyperalgesia, pubmed-meshheading:14557564-Injections, Intradermal, pubmed-meshheading:14557564-Male, pubmed-meshheading:14557564-Nerve Fibers, Myelinated, pubmed-meshheading:14557564-Nerve Fibers, Unmyelinated, pubmed-meshheading:14557564-Pain, pubmed-meshheading:14557564-Pain Measurement, pubmed-meshheading:14557564-Pain Threshold, pubmed-meshheading:14557564-Placebos, pubmed-meshheading:14557564-Reference Values, pubmed-meshheading:14557564-Skin, pubmed-meshheading:14557564-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A.
pubmed:affiliation
Department of Clinical Pharmacology, University of Vienna, Austria. vollerb@ninds.nih.gov
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't